MacroGenics | Egenkapital Og Reserver



Equity Capital And Reserves Endring Dato
AbbVie USD 3.32B 2.71B 2024-12
Amgen USD 5.88B 1.65B 2024-12
AstraZeneca USD 40.87B 66M 2024-12
Biogen USD 16.72B 357.1M 2024-12
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Daiichi Sankyo JPY 1.62T 1.57B 2024-12
Eli Lilly USD 14.19B 47.9M 2024-12
Genmab DKK 36.7B 4.78B 2024-12
Geron USD 280.32M 11.96M 2024-12
Gilead Sciences USD 19.33B 856M 2024-12
J&J USD 71.49B 1.33B 2024-12
MacroGenics USD 116.06M 4.01M 2024-12
Merck USD 46.31B 1.81B 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Regeneron Pharmaceuticals USD 29.35B 27.7M 2024-12
Roche Holding CHF 36.16B 3.28B 2024-12
Xencor USD 677.61M 46.22M 2024-12



MacroGenics Egenkapital Og Reserver - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.